![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
The increasing knowledge of the exact biochemical nature of the localized and systemic amyloid disorders has made a logical and easily understood nomenclature absolutely necessary. Such a nomenclature, biochemically based, has been used for several years but the current literature is still mixed up with many clinical and histochemically based designations from the time when amyloid in general was poorly understood. All amyloid types are today preferably named by their major fibril protein. This makes a simple and rational nomenclature for the increasing number of amyloid disorders known in humans and animals.
Keywords:
| Abbreviations | ||
| AβPP | = | Aβ peptide precursor; |
| FAC | = | familial amyloidotic cardiomyopathy; |
| FAP | = | familial amyloidotic polyneuropathy |
| Abbreviations | ||
| AβPP | = | Aβ peptide precursor; |
| FAC | = | familial amyloidotic cardiomyopathy; |
| FAP | = | familial amyloidotic polyneuropathy |